INSANE: Bmy - The Real Truth

Turn Bristol-Myers Squibb into an Income Machine with This Options Play

With markets coming in to a volatile time of year, investors might be more interested in generating income rather than capital gains.

Barchart · Aug 20

The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today

Bristol-Myers stock extends gains on reports of a potential merger with AstraZeneca. But caution is warranted in chasing the momentum in BMY shares today.

Barchart · Aug 3

AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus

As per a media report over the weekend, AstraZeneca Plc (NYSE:AZN) and Bristol Myers Squibb Co. (NYSE:BMY) are in potential discussions to form a pharmaceutical giant valued at nearly $400 billion.

Benzinga · Aug 3

Bristol-Myers Squibb Stock Rises on Anthropic AI Deal. Why This Could Actually Be a Key Upside Catalyst.

BMY stock rose after the company announced a strategic AI deal with Anthropic to deploy Claude across its workforce.

Barchart · May 22

Bloomsbury Publishing H2 Earnings Call Highlights

Bloomsbury Publishing (LON:BMY) reported higher profit and earnings despite a year-over-year revenue decline, as management pointed to the resilience of its mix of consumer and academic publishing and said it expects to deliver record profit in the current financial year. Founder and Chief Executiv

MarketBeat · May 20

Do Wall Street Analysts Like Bristol-Myers Squibb Stock?

Although Bristol-Myers Squibb has lagged behind the SPX over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart · Apr 29

Bristol-Myers Squibb Earnings Preview: What to Expect

Bristol-Myers Squibb is approaching its first-quarter earnings release this month, and Wall Street is forecasting a double-digit percentage fall in earnings.

Barchart · Apr 9

Is Bristol-Myers Squibb Stock Underperforming the Nasdaq?

Though Bristol-Myers Squibb has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart · Feb 27

Stocks Retreat as Tech Stocks Fall and the US Labor Market Weakens

The S&P 500 Index ($SPX ) (SPY ) today is down -1.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.49%. March E-mini S&P futures (ESH26 ) are down -1.29%, and March E-mini Nasdaq futures...

Barchart · Feb 5

Bristol-Myers Squibb Stock Outlook: Is Wall Street Bullish or Bearish?

Bristol-Myers Squibb has lagged the broader market over the past year, but analysts are growing optimistic about the company’s outlook.

Barchart · Jan 28